UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Inquiry Search clinical trials

Name
UMIN ID

Unique ID issued by UMIN UMIN000010319
Receipt No. R000012078
Scientific Title Phase II study of TS-1+Irinotecan+Bevacizumab as second-line treatment in patients with metastatic colorectal cancer refractory to fluoronated pyrimidine, oxaliplatin, and cetuximab therapy
Date of disclosure of the study information 2013/03/26
Last modified on 2016/11/24 15:00:59

No. Disposal Last modified on Item of update
1 Insert 2013/03/26 17:22:13
2 Update 2016/11/24 13:15:13 Key inclusion criteria
3 Update 2016/11/24 14:50:11 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of primary sponsor
Institute
Organization
Organization
Address1
4 Update 2016/11/24 14:50:43 Recruitment status
Publication of results
5 Update 2016/11/24 15:00:59 Recruitment status


Contact us.